Did you know that one of Québec’s most advanced brachytherapy department’s is at Hôpital Charles-Le Moyne?
The brachytherapy department at Centre intégré de cancérologie de la Montérégie (CICM) is catching the medical community’s attention—here and around the world. It recently welcomed some 40 specialists from Canada and abroad who were attending the Curietherapies Annual Conference.
With comprehensive services, an experienced team and unique ENT expertise, the CICM is now an international reference.
And that’s not all. Since the beginning of 2024, 415 patients have already received brachytherapy treatment, right here, in the Montérégie!
🩺 The CICM also has you to thank.
In 2011, your donations funded the creation of the CICM. Since then, your generosity has continued to support this centre, in particular, by funding a second radioactive source projector—a key component for the brachytherapy department.
Your impact is real. Thank you for transforming care, one gesture at a time. 💙
📖 To read in French only: Un service de curiethérapie de renommée internationale
For those who are wondering: What is brachytherapy?
It’s ultra-targeted radiotherapy, where a radioactive source is placed as close as possible to the tumour, inside the patient’s body. Used to treat prostate, breast and gynecological cancers, this approach is more effective in preserving healthy tissue, with less side effects—and precision, where every millimetre counts.
